Literature DB >> 11467076

The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design.

R J Broadbridge1, R P Sharma.   

Abstract

Src homology 2 (SH2) domains are found in many intercellular signal-transduction proteins which bind phosphotyrosine containing polypeptide sequences with high affinity and specificity and are considered potential targets for drug discovery. The protein p56lck is a member of the family of Src tyrosine kinase. The SH2 domain is thought to be responsible for the recruitment and regulation of p56lck kinase activity. There have been enormous efforts in the development of SH2 domain inhibitors for diseases such as cancer, osteoporosis and other diseases. This review focuses on current understanding of SH2 domain structure, mechanism and drug discovery with an emphasis on p56lck SH2 domain. A potential impact of the accumulated crystallographic effort on the development of methods for structure-based drug design is briefly addressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11467076     DOI: 10.2174/1389450003349074

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  2 in total

1.  Inhibition of protein-protein interactions with low molecular weight compounds.

Authors:  Marilyn M Matthews; David J Weber; Paul S Shapiro; Andrew Coop; Alexander D Mackerell
Journal:  Curr Trends Med Chem       Date:  2008-01-01

2.  Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids.

Authors:  Won Jun Choi; Sung-Eun Kim; Andrew G Stephen; Iwona Weidlich; Alessio Giubellino; Fa Liu; Karen M Worthy; Lakshman Bindu; Matthew J Fivash; Marc C Nicklaus; Donald P Bottaro; Robert J Fisher; Terrence R Burke
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.